BBNX: betabionics.com Growth-Adjusted Market Cap to Net Income
Patents and FDA certifications protect the market positions of Beta Bionics Inc (BBNX) from new entrants. Recurring revenue is driven by the continuous sale of diabetes control consumables. High margins are based on AI-driven insulin dosing algorithms. The P/E to growth rate dynamics on GURU.Markets reveal the current trend, where the value of 0.00 expresses the metric level.
Beta Bionics Inc (BBNX) - metric breakdowns and financial figures
- current price and projected stock value:
- market capitalization information:
- company book value details:
- business debt structure and liquidity details:
- earnings and valuation multiples indicators:
BBNX - Net Profit|Company Profit Forecast Beta Bionics Inc|BBNX - P/E Multiple|Projected Price to Earnings iLet Bionic Pancreas|BBNX - PEG Multiple|EV/EBITDA Multiple Beta Bionics Corp|BBNX - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Beta Bionics|BBNX - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months betabionics.com|BBNX - Earnings growth in current year|Expected net earnings per share growth next year Beta Bionics Inc
Fundamental company analysis:BBNX (Beta Bionics, Inc.)
For Beta Bionics Inc (BBNX), which is protected by FDA barriers and a unique dosing algorithm, this indicator determines the fair value of shares through the lens of business expansion. By analyzing the P/E ratio divided by the growth rate, an investor identifies the asset's undervaluation: values below one confirm that the market price does not fully price in the potential of the company's technological advantage.
Competing companies
Price/Earnings to Growth Ratio BSX (Boston Scientific Corp)|PEG Multiple EW (Edwards Lifesciences Corp)|Growth-Adjusted Market Cap to Net Income ResMed Corporation (RMD)|PODD: Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio ZBH|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Invisalign (ALGN)|GMED (Globus Medical Corp) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (transmedics.com)|Price/Earnings to Growth Multiple ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis ENOV|IART - Price/Earnings to Growth Multiple|Motiva - PEG Multiple|Price to Earnings Adjusted for Growth Rate IRADIMED Inc.|EMBC: PEG Multiple|Growth-Adjusted P/E Ratio TNDM|AXGN (Axogen) - PEG Multiple|SI-BONE Inc (SIBN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple OFIX|Price/Earnings to Growth Multiple Bioventus Global BVS|PEG Multiple KIDS (OrthoPediatrics)|PEG Multiple treace.com TMCI|SRTA - Price/Earnings to Growth Ratio|CARL: Price/Earnings to Growth Ratio|RXST (RxSight Corp) - Price/Earnings to Growth Multiple|ClearPoint Neuro - Growth-Adjusted Payback Ratio|STXS (Stereotaxis, Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate neurostar.com STIM|Price/Earnings to Growth Ratio Sight Sciences (SGHT)|Orchestra BioMed Inc. (OBIO) - Price to Net Income Growth Ratio|Anika Therapeutics, Inc. - Price/Earnings to Growth Multiple|PEG Multiple InspireMD Inc. NSPR|Jin Medical International Ltd - PEG Multiple|Growth-Adjusted Market Cap to Net Income Vivani Medical, Inc. VANI|xtantmedical.com (XTNT) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne)|Price/Earnings to Growth Ratio Modular Medical Inc|Price/Earnings to Growth Multiple Myomo Inc (MYO)|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical Corp. NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|Lifeward Ltd. - Company Value to Earnings Growth Ratio|AMIX: PEG Multiple|IVF (invobioscience.com) - Price/Earnings to Growth Ratio|BBLG (Bone Biologics Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Axonics Inc. AXNX|Price/Earnings to Growth Multiple BIOL (Biolase, Inc.)|Company Value to Earnings Growth Ratio DYNT|PEG Multiple FNA (Paragon 28)|PEG Multiple INVO Bioscience Inc. INVO
